Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 059405/0991 | |
| Pages: | 4 |
| | Recorded: | 03/25/2022 | | |
Attorney Dkt #: | SHE0508.PCT |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
05/03/2022
|
Application #:
|
16490443
|
Filing Dt:
|
08/30/2019
|
Publication #:
|
|
Pub Dt:
|
01/16/2020
| | |
PCT #:
|
US2018020514
|
Title:
|
IMMUNOTHERAPEUTIC TREATMENT METHOD USING AN INTERLEUKIN-2 RECEPTOR BETA-SELECTIVE AGONIST IN COMBINATION WITH ADOPTIVE CELL TRANSFER THERAPY
|
|
Assignee
|
|
|
455 MISSION BAY BOULEVARD SOUTH |
SUITE 100 |
SAN FRANCISCO, CALIFORNIA 94158 |
|
Correspondence name and address
|
|
NEKTAR THERAPEUTICS
|
|
455 MISSION BAY BOULEVARD SOUTH
|
|
SUITE 100
|
|
SAN FRANCISCO, CA 94158
|
Search Results as of:
05/28/2024 07:01 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|